Medically reviewed by Angela, RN

23+ years clinical experience | National Trainer, Aesthetic Medicine

Last reviewed: August 2026

You've been doing this long enough to schedule it into your calendar like a dentist appointment. Every three months, same routine, same face — and it works. But somewhere around year three, you start doing the math: four appointments a year, indefinitely. And you start wondering whether there's a version of this that doesn't live in the quarterly rotation.

That's the question most people have when they ask about Daxxify. Not "is it better?" — most experienced patients already know there isn't a simple answer to that — but "is the math and the ingredients different enough that it changes anything for me?" For some patients, it is. 

This guide covers both products honestly: what each contains, how long the results actually last (the trial data is more specific than what circulates online), what it costs, and how to decide.

Both Daxxify® and Botox® Cosmetic are purified botulinum toxin type A, approved for frown lines in adults, and work by temporarily blocking the nerve signal that makes those muscles contract. The main differences: Daxxify's trials showed a longer median duration, it's formulated without human- or animal-derived ingredients, making it the ONLY Vegan, peptide and amino acid powered neuromodulator on the market, and it generally costs the same per treatment. Botox has four FDA-approved cosmetic areas versus Daxxify's one, and a much longer clinical track record.

	Daxxify®	Botox® Cosmetic
Active ingredient	daxibotulinumtoxinA-lanm	onabotulinumtoxinA
Maker	Revance / Crown Laboratories	Allergan Aesthetics (AbbVie)
FDA-approved cosmetic areas	Glabellar lines only. Other areas can be treated safely off label.	Glabellar lines, crow's feet, forehead lines, platysma bands
Stabilizing ingredient	Synthetic peptide (RTP004)	Human serum albumin
Human- or animal-derived components	None	Human serum albumin (human blood–derived)
Time to first visible change	2-5 days (published trial diaries)	5-7 days (per label pharmacodynamics)
Typical duration	~5.5-month trial median; real-world results vary	3–4 months
Approved frown-line dose	40 Units	20 Units
Year FDA approved (cosmetic)	2022	Early 2000s
Relative cost per treatment	Same or slightly higher	Baseline

 

What Daxxify and Botox Actually Are

Both products belong to a class of medications called neuromodulators — prescription drugs that temporarily reduce muscle movement by blocking nerve signals. In the case of frown lines (the vertical "11s" between the brows, technically called glabellar lines), that means the corrugator and procerus muscles — the ones that pull the brows together — contract less forcefully, and the lines they create soften.

Neither product "freezes" the face. A well-placed treatment reduces intensity, not expression. The goal, and the result when it's done well, is that you look less tired or tense — not like you haven't moved your face.

Daxxify® (daxibotulinumtoxinA-lanm) received FDA approval for glabellar lines in September 2022, making it the newest major entry in this category. Botox® Cosmetic has been in aesthetic use for over two decades. That difference in track record is one of Botox's genuine advantages. Both products are manufactured by different companies using different processes and formulations — which is why their unit systems are not interchangeable, and why comparing them carefully matters.

The Peptide Difference — What's Actually in the Vial

Every injectable neuromodulator contains a stabilizing ingredient to protect the toxin molecule through storage and handling. For most products — including Botox® Cosmetic, Xeomin, and Dysport® — that stabilizer is human serum albumin, a protein derived from human blood.

Daxxify uses something different: a synthetic 35-amino-acid peptide called RTP004, developed using what Revance calls Peptide Exchange Technology™. The result, verifiable directly from the FDA label's excipient list, is a formulation containing no human serum albumin and no animal-derived components. The inactive ingredients are L-histidine, L-histidine hydrochloride monohydrate, polysorbate 20, RTP004 peptide (11.7 mcg), and trehalose dihydrate — a short list, and a checkable one.

For comparison: Botox® Cosmetic and Xeomin both contain human serum albumin. Dysport® contains human serum albumin and may also contain trace cow's milk protein.

Who this matters to: If you follow a vegan or vegetarian diet and prefer to avoid animal- or blood-derived ingredients, Daxxify is the only FDA-approved neuromodulator in the US formulated that way. The same applies if you have religious or personal objections to blood-derived products, or if you simply prefer a shorter, synthetic ingredient list. This is a real, verifiable difference — and one that most articles reduce to a buzzword and move on from.

One thing worth saying clearly, because no competing article does: an animal-free ingredient list is not the same as an animal-free product history. Botulinum toxin development and regulatory approval have historically involved animal testing across every product in this category. That's a statement about product development, not about what's in the vial today — and it's worth knowing the difference.

What the formulation difference does not mean: it hasn't been shown to make Daxxify safer, less allergenic, or more resistant to antibody development. The ingredient preference is real. A clinical superiority claim based on it is not established, and this article won't make one.

How Long Does Daxxify Last — and Does It Really Last Longer Than Botox?

This is the question the article is really here to answer — and where the honest version differs meaningfully from what circulates online.

In the SAKURA 1 and SAKURA 2 pivotal trials, researchers measured how long patients maintained none or mild glabellar line severity after a single treatment. The median duration was 24.0 and 23.9 weeks — roughly five and a half months. That's the right number to know, and it's more useful than a bare "six months" because it names the endpoint and tells you where the middle of the distribution sits.

What the response curve looks like:

• Week 16 (about four months): approximately 71–74% of patients still had none or mild severity
• Week 20 (about five months): approximately 53–54%
• Week 24 (about six months): approximately 29–35%
• Week 36 (about nine months): approximately 3–5%

"Lasts six months" describes a minority — roughly one in three patients at six months still had none or mild frown lines. Most patients are retreating before six months arrives. And "up to nine months" describes 3–5% of patients in the trials; it's technically true and clinically nearly irrelevant.

Here's where the Daxxify case is genuinely strong: about 70% of patients still had the result at four months — right about when the typical Botox appointment would come due. That's the practical argument. Not the outlier at nine months, but the real extension of the window before most patients need to return. The practical translation for most people is two to three Daxxify treatments a year instead of three to four Botox appointments. For anyone driving in from Post Falls, Hayden, Sandpoint, or the Spokane area, fewer annual trips is a real quality-of-life consideration.

Botox® Cosmetic typically lasts three to four months.

One important caveat: this duration data comes from frown lines specifically. The SAKURA trials measured glabellar results. How long Daxxify lasts in the forehead, around the eyes, or in the masseter is less well characterized, and extrapolating the six-month number to other areas would go beyond what the evidence supports.

How Long Does Daxxify Take to Work?

In the published SAKURA patient diaries, the median onset was three days in each study. Some patients reported noticing early softening as early as day one.

A day-by-day picture:

• Day 1: some patients notice early softening
• Day 3: median onset in the published trials — most patients see the first real change here
• Days 7–14: the effect continues developing
• Day 14: the appropriate point to judge the result and schedule any touch-up assessment

For comparison: Botox® Cosmetic's prescribing information states that initial doses "induce chemical denervation of the injected muscles one to two days after injection, increasing in intensity during the first week." These two figures measure different things — Daxxify's is patient-reported visible improvement from a diary; Botox's is a pharmacodynamic statement from the label — but the conclusion holds: both products begin working within a few days, and both take about two weeks to reach full effect. The widely repeated claim that Daxxify works dramatically faster than Botox isn't supported by the evidence.

Book at least two weeks before anything that matters. If you're at day five and not seeing much, give it the full 14 days before drawing any conclusions.

What Daxxify Costs — and the Math That Actually Matters

Daxxify often costs slightly more per treatment than Botox® Cosmetic. That's the honest answer, and we'd rather say it here than have you find out at the front desk.

Part of the confusion around pricing comes from how units are quoted. Daxxify's approved frown-line dose is 40 Units; Botox's is 20 Units. Some practices price Daxxify lower per unit, which creates the impression it costs less — but the unit count for a comparable treatment is higher, so the total treatment price is generally higher.

An important note on that 40-vs-20 relationship: those unit numbers are not a potency conversion. Daxxify's label states its potency units are specific to that product and test method, and are not interchangeable with any other botulinum toxin. Comparing price per unit across brands is like comparing two prices measured in different currencies — the numbers don't translate.

The more useful comparison is cost per month of effect. If a Botox treatment lasts three months and a Daxxify treatment lasts roughly five and a half months at the trial median, a higher per-treatment Daxxify price can work out to comparable or lower annual cost — plus fewer appointments and fewer trips. That math isn't guaranteed; your real-world duration will vary. But it's the honest way to think about it.

Insurance doesn't cover cosmetic neurotoxin treatments. For specific pricing at Renew, a consultation is the right starting point — cost depends on the area being treated and the dose appropriate for your anatomy.

Where Each One Tends to Be Used

Frown lines ("11s")

The only FDA-approved cosmetic area for Daxxify in the United States. This is also where all of Daxxify's duration data was collected — the SAKURA trials measured glabellar results specifically. The five-to-six-month figure was established here, and extrapolating it to other areas would go beyond what the evidence supports.

Forehead lines and around the eyes

Off-label for Daxxify — meaning the FDA has approved the drug, but not specifically for these uses. Off-label prescribing is legal and routine in medicine, and treating the forehead and crow's feet with any neuromodulator is standard clinical practice. For reference: Botox® Cosmetic holds approved indications for both forehead lines and lateral canthal lines (crow's feet); Xeomin received an upper facial lines approval in July 2024. Duration in these regions for Daxxify is less well characterized than in the glabella.

Jawline and masseter treatment

Off-label for both Daxxify and Botox® Cosmetic. (As of August 2026, an Allergan supplemental application for Botox® Cosmetic for masseter muscle prominence has been accepted by the FDA — accepted is not the same as approved, and masseter treatment with any neuromodulator remains off-label as of this writing.) Injections into the masseter — the powerful chewing muscle at the jaw angle — are used to address clenching, grinding, and to soften a heavily squared jaw. Results take longer to develop here than in the forehead (typically four to six weeks) and often improve after a second treatment cycle. Appropriate dosing is determined by your injector based on your anatomy and goals.

Neck and around the mouth

Off-label for Daxxify. Platysma bands — the vertical cords that appear in the neck — received FDA approval for Botox® Cosmetic in October 2024. Perioral treatments are off-label for all neuromodulators. These are technically demanding areas where a longer-acting product argues for conservative initial dosing.

What Daxxify Before-and-After Photos Actually Show You

Before-and-after photos are the most-searched content in this topic area and the least reliably interpreted. A few things worth knowing before you evaluate them.

Same angle, same lighting, same expression. A "before" at full frown next to an "after" at rest isn't a comparison — it's a setup. Photos that tell you something show consistent conditions on both sides.

Interval labeled — and for Daxxify, this matters more than usual. A two-week result and a five-month result look different and prove different things. An undated Daxxify before-and-after proves nothing about duration. If a gallery doesn't timestamp its photos, you don't know what you're looking at.

Softened, not erased. Dynamic lines — the ones that appear primarily with expression — respond fastest. Static lines etched over years soften gradually across multiple treatment cycles. The first treatment is often the start of a process, not a transformation.

At Renew, we publish only before-and-after photos from our own consented patients, with consistent lighting, no retouching, and labeled treatment intervals. If you'd like to see examples of our Daxxify or Botox results, we're happy to show them at a consultation.

Is Daxxify or Botox Right for You?

Daxxify tends to be a strong fit if:

• You're a long-time neurotoxin patient who wants fewer annual appointments
• You follow a vegan or vegetarian diet and want to avoid human- or animal-derived ingredients
• You have personal or religious reasons to avoid blood-derived products like human serum albumin
• Your primary concern is frown lines, where Daxxify's duration data is the most solid
• You travel from outside the immediate area and fewer annual appointments has genuine practical value

Botox® Cosmetic may be the better fit if:

• You've never had a neuromodulator. If you don't yet know how you'll respond, committing to six months of an experience you haven't had is a bigger step than committing to three. Starting shorter-acting and switching once you know how you respond is a perfectly sound approach.
• You want treatment in areas beyond the glabella — forehead, crow's feet, or neck — where Botox has approved indications and an established duration base.
• You have meaningful facial asymmetry or a history of results you weren't happy with, where a shorter-acting product gives you more flexibility to adjust.
• You're treating an area ahead of a specific event, after which you'd prefer the effect to wear off on a shorter timeline.

Everyone should have a conversation with their injector first if they are pregnant or plan to become pregnant, breastfeeding; neuromuscular disorders such as myasthenia gravis, Lambert-Eaton syndrome, or ALS; difficulty swallowing or breathing; bleeding disorders or anticoagulant medications; active infection near the injection site; or known allergy to any botulinum toxin preparation.

And for anyone on the fence: not treating at all is a valid choice. There's no urgency here.

What to Expect — Your Appointment and the First 24 Hours

Both products are administered the same way: a brief in-office visit, typically 15 to 30 minutes once the consultation is complete, with a very fine needle into specific muscles. There's no required downtime, and most patients return to their normal day immediately.

At Renew, the appointment starts with a real conversation — your goals, your history with any prior treatments, and what you're hoping to see. We assess muscle movement at rest and with expression, then determine placement and dosing based on your anatomy. If there's any reason we think a different approach would serve you better, we'll say so before we proceed.

Early softening often begins within the first few days, with the effect developing gradually through the first week and reaching full expression at around 14 days. That's the right time to assess the result — not day three. If a touch-up is warranted, we schedule it at the two-week point.

Aftercare: Stay upright for about four hours; avoid rubbing or massaging the treated area for 24 hours; skip strenuous exercise, hot tubs, and saunas for about 24 hours; wait roughly four hours before applying makeup and apply it gently. Alcohol is best skipped the day of treatment — the concern is bruising risk, not an interaction with the product. Some of these rules are clinical convention rather than evidence-backed guidelines with precise trial data; they represent reasonable precaution and cost you nothing to follow.

Risks, Side Effects, and the Trade-Off Nobody Mentions

The most commonly reported side effects in the Daxxify glabellar trials were headache (6%), eyelid ptosis — temporary drooping of the upper eyelid (2%), and facial paresis — temporary local muscle weakness (1%). Injection-site redness, swelling, and small bruises are common with any injectable and typically resolve within a few days.

Like all botulinum toxin products, Daxxify carries a boxed warning about the potential spread of toxin effect beyond the injection site, which in rare cases may cause swallowing or breathing difficulties. This warning applies across the entire class of neuromodulators. It is the reason these treatments belong in the hands of a licensed, experienced clinician — not a reason to avoid the category if it's appropriate for you.

The trade-off nobody mentions: A longer-acting product means that unwanted results also last longer. A brow that feels heavier than you expected, a result slightly more than you wanted, or an asymmetry needing adjustment — any of those resolve more slowly with a product measured in months rather than weeks. Most side effects are mild and temporary regardless, and most asymmetry can be corrected. But this is a genuine consideration, and it's a strong argument for starting conservatively and working with an experienced injector.

Frequently Asked Questions

How long does Daxxify last?

In the SAKURA trials, the median time patients maintained none or mild frown line severity was about 24 weeks — roughly five and a half months. About 70% still had the result at four months, about half at five months, and about a third at six. Meaningfully longer than Botox's typical three to four months, but "six months for everyone" isn't the accurate reading of the data. Real-world duration also varies with dose, treatment area, and individual metabolism.

Is Daxxify vegan?

Its ingredient list contains no human- or animal-derived components — stabilized by a synthetic peptide rather than the human blood–derived albumin used in Botox, Xeomin, and Dysport. That makes it the practical option if you follow a vegan or vegetarian diet and prefer to avoid those ingredients. To be precise: that's a statement about what's in the vial, not a claim about the product's full development history — which wouldn't be animal-free for any botulinum toxin on the market.

Does the peptide formulation make Daxxify safer?

There's no evidence that it does. The formulation difference is about ingredient preference, not a demonstrated clinical safety advantage. Both products carry the same class of boxed warning, and their side-effect profiles are broadly similar. Choose based on what you care about in an ingredient list — not on a safety claim that hasn't been established.

Is Daxxify cheaper than Botox?

Per unit, it's sometimes priced lower — which is where that impression comes from. But the approved frown-line dose is 40 Units versus Botox's 20, so total treatment cost is generally higher. And those unit numbers aren't a conversion factor: Daxxify's label states its units are product-specific and not interchangeable with any other neurotoxin. The more useful comparison is cost per month of effect, where Daxxify's math can make sense.

What if I don't like the result — am I stuck with it?

This is the honest trade-off of a longer-acting product. Most side effects are mild and temporary either way, and most asymmetry can be adjusted. But an unwanted result that would resolve in a few weeks with a shorter-acting product may take longer here. It's a real consideration, and one reason we often start conservatively with first-time Daxxify patients.

Should Daxxify be my first neurotoxin?

It can be — but there's a reasonable argument for starting with a shorter-acting product if you've never had a neuromodulator before. You don't yet know how you'll feel about the result, and committing to roughly six months of an experience you haven't had is a bigger step than committing to three. We'll give you a candid recommendation either way at your consultation.

The Bottom Line

Daxxify offers two things Botox® Cosmetic doesn't: a longer median duration in the trials — roughly five and a half months versus three to four — and a formulation with no human- or animal-derived ingredients. Both of those are real, verifiable, and worth a genuine conversation. Neither makes it automatically the right choice.

Botox has a two-decade track record, four FDA-approved cosmetic areas versus Daxxify's one, and a lower per-treatment cost. For first-time patients, patients treating areas beyond the glabella, or anyone who would prefer a shorter commitment, it remains a strong option.

Daxxify isn't automatically the better choice — it may cost more, and if you've never had a neuromodulator before, there's a solid argument for starting shorter. What it offers is fewer appointments a year and a synthetic ingredient list, which for some patients is the whole decision.

If you'd like a straight answer about which makes more sense for your situation — or an honest opinion that neither does right now — book a consultation at our Coeur d'Alene office or call us at (208) 930-6823. We see patients from across the Coeur d'Alene area, including Post Falls, Hayden, Sandpoint, and the greater Spokane region. We'll tell you honestly what we think before you commit to anything.

This article is for educational purposes only and is not a substitute for medical advice, diagnosis, or treatment. Therapies discussed may include off-label prescribing; off-label prescribing is legal and common in medicine but means the FDA has not specifically approved the medication for the use described. Individual results vary, including duration of effect. Botulinum toxin products carry a boxed warning regarding the distant spread of toxin effects. Speak with a licensed clinician about your individual health history before starting any treatment. DAXXIFY® is a registered trademark of Revance Therapeutics, Inc., a Crown Laboratories company. BOTOX® Cosmetic is a registered trademark of Allergan, Inc. Last medically reviewed: August 2026 by Angela, RN.

Citations

1. Daxxify (daxibotulinumtoxinA-lanm) Prescribing Information. U.S. Food & Drug Administration. FDA.gov

2. Botox Cosmetic (onabotulinumtoxinA) Prescribing Information. U.S. Food & Drug Administration. FDA.gov

3. Bertucci V, et al. "Daxibotulinumtoxin A for Injection for the Treatment of Glabellar Lines: Results from SAKURA 1 and SAKURA 2." Plastic and Reconstructive Surgery. 2020. PubMed

4. U.S. FDA Novel Drug Approvals 2022 — Daxxify approval, September 2022. FDA.gov

5. AbbVie / Allergan. FDA Accepts Supplemental BLA for BOTOX Cosmetic for Masseter Muscle Prominence. August 4, 2026. AbbVie Newsroom

6. AbbVie / Allergan. FDA Approves BOTOX Cosmetic for Platysma Bands. October 18, 2024. AbbVie Newsroom

7. Xeomin Prescribing Information — July 2024 upper facial lines approval. U.S. Food & Drug Administration. FDA.gov